AI Insight
This study conducted a comprehensive mapping of N6-methyladenosine (m6A) RNA modifications, a form of epitranscriptomic regulation, across five distinct human brain regions and multiple developmental stages. The researchers identified significant spatial variation, meaning m6A patterns differ between brain regions, as well as temporal variation, meaning these patterns change with age. Notably, genes carrying these modifications are preferentially associated with neurological and psychiatric diseases, and the m6A sites show colocalization with known genetic risk loci for brain disorders.
Why it matters
These findings suggest that m6A epitranscriptomic regulation may play a meaningful role in the biological mechanisms underlying neurological and psychiatric conditions, potentially opening new avenues for understanding disease etiology beyond DNA-level genetic risk. Identifying region- and age-specific modification patterns could inform more targeted therapeutic strategies for brain disorders.
Nature Neuroscience, Published online: 09 December 2025; doi:10.1038/s41593-025-02112-z
Epitranscriptomic (m6A) profiling across five human brain regions and developmental stages uncovers region-specific and age-specific dynamics, preferential enrichment in disease-associated genes, and colocalization with disease risk loci.